Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.
about
Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents.Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyNonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus17-β Estradiol reduces atherosclerosis without exacerbating lupus in ovariectomized systemic lupus erythematosus-susceptible LDLr(-/-) mice.LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus.Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study.Pregnancy and renal outcomes in lupus nephritis: an update and guide to management.Clinical Trials With Mesenchymal Stem Cells: An Update.Prevalence of premature ovarian failure in patients with systemic lupus erythematosus.Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.Infertility today: the management of female medical causes.Age at natural menopause among patients with systemic lupus erythematosus.The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers.Fertility preservation for medical reasons in girls and women: British fertility society policy and practice guideline.
P2860
Q33380516-E71FB542-A845-42FA-9AA7-A7895F4895E1Q34954883-B55BEE00-84CD-4252-8A8F-024CEA739C2FQ35267073-F98ECC88-FD11-4011-BB25-89334830B2AEQ35606420-6896EBF6-0D92-4B29-BFC5-DEA15A86A309Q35827846-46F746FD-1698-4881-B72C-41CCC2808280Q36746168-20355A07-ED3A-48DA-800D-6459A0944DD8Q36787315-4505A2B2-FD20-4E90-B1A5-C48C627A92B0Q37312560-AEEAADA8-A0CA-48A9-B593-1BF708EC895AQ38033398-BB165864-34ED-45FC-A78C-67F94E5BC2F0Q38596084-74773E36-61B1-4F51-A585-77680437EDA1Q40200817-9280CB7E-EFE8-4AB7-85EC-BF7C8812E945Q40259370-8ACED70E-4B5D-43FC-BD9D-58F0F88B0EF2Q40828932-59AB49AE-CC02-4AC1-A7B8-F45A4C26626AQ43486705-F291F2EE-DDBD-4050-9CE0-8F8F5CA72E01Q43519793-A7548D0D-225F-43B9-B8A8-5EBB4ED97A94Q44206742-4F6D5028-8B22-43B8-9862-34F17E9BF1C5Q46554198-2551D9DE-7152-4645-ACC7-255A9D023747Q47094970-7B5FEFC7-90C1-4A93-9A45-A7F6D07BA4B4Q47558016-754B3068-6D8E-483A-90F8-7325A5CB60B5
P2860
Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Ovarian failure in systemic lu ...... intravenous cyclophosphamide.
@ast
Ovarian failure in systemic lu ...... intravenous cyclophosphamide.
@en
type
label
Ovarian failure in systemic lu ...... intravenous cyclophosphamide.
@ast
Ovarian failure in systemic lu ...... intravenous cyclophosphamide.
@en
prefLabel
Ovarian failure in systemic lu ...... intravenous cyclophosphamide.
@ast
Ovarian failure in systemic lu ...... intravenous cyclophosphamide.
@en
P2860
P1433
P1476
Ovarian failure in systemic lu ...... intravenous cyclophosphamide.
@en
P2093
A G Tzioufas
G E Katsifis
P2860
P304
P356
10.1191/0961203304LU2012OA
P577
2004-01-01T00:00:00Z